William Fairey - Apr 18, 2024 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
Apr 18, 2024
Transactions value $
$0
Form type
3
Date filed
4/22/2024, 04:34 PM
Previous filing
Nov 2, 2023
Next filing
Jun 7, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.